A comprehensive prognostic and immunological analysis of hexokinase domain containing protein-1 (HKDC1) in pan-cancer

Background Currently, research on the role of hexokinase domain-containing protein-1 (HKDC1) in neoplasm metabolism remains sparse. This study seeks to conduct a thorough investigation of HKDC1’s potential functions across thirty-three different tumor types, utilizing data obtained from The Cancer G...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhi Liang, Tianhao Zhang, Jiajia Huang, Zhixin Huang, Zeyu Zhao, Shirong Cai, Jinping Ma
Format: Article
Language:English
Published: PeerJ Inc. 2025-03-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/19083.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850058908083683328
author Zhi Liang
Tianhao Zhang
Jiajia Huang
Zhixin Huang
Zeyu Zhao
Shirong Cai
Jinping Ma
author_facet Zhi Liang
Tianhao Zhang
Jiajia Huang
Zhixin Huang
Zeyu Zhao
Shirong Cai
Jinping Ma
author_sort Zhi Liang
collection DOAJ
description Background Currently, research on the role of hexokinase domain-containing protein-1 (HKDC1) in neoplasm metabolism remains sparse. This study seeks to conduct a thorough investigation of HKDC1’s potential functions across thirty-three different tumor types, utilizing data obtained from The Cancer Genome Atlas (TCGA). Method We conducted a thorough data extraction from the TCGA database, subsequently employing R (version 4.2.2) and its associated software packages for detailed analysis. Our investigation centered on evaluating the differential expression and prognostic significance of HKDC1, while also examining its connections to tumor heterogeneity, mutation profiles, and RNA modifications. Furthermore, we analyzed the relationship between HKDC1 expression and tumor immunity utilizing the TIMER analysis approach. Results A comprehensive analysis of various tumor types has revealed that HKDC1 is significantly upregulated in many malignant tumors. Importantly, patients with elevated HKDC1 levels in their tumor tissues often experience poorer prognoses. The association between HKDC1 expression, immune cell infiltration, and the existence of immune checkpoints suggests a possible connection between the tumor microenvironment and HKDC1, alongside tumor advancement. Gene set enrichment analysis (GSEA) further substantiates the idea that HKDC1 may play a role in several critical pathways and biological processes associated with neoplasm. Additionally, the overexpression of HKDC1 is influenced by promoter methylation and alterations in DNA copy number amplification. Furthermore, in vitro experiments demonstrated that silencing HKDC1 resulted in a marked reduction in the proliferation, migration, and invasion capabilities of neoplasm cells. Conclusion Our initial pan-cancer analysis provided a comprehensive understanding of the oncogenic roles of HKDC1 across diverse cancer types. Moreover, HKDC1 has the potential to serve as a significant prognostic biomarker.
format Article
id doaj-art-e80fff41daac40c4b1c126ae1e217c37
institution DOAJ
issn 2167-8359
language English
publishDate 2025-03-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj-art-e80fff41daac40c4b1c126ae1e217c372025-08-20T02:51:00ZengPeerJ Inc.PeerJ2167-83592025-03-0113e1908310.7717/peerj.19083A comprehensive prognostic and immunological analysis of hexokinase domain containing protein-1 (HKDC1) in pan-cancerZhi Liang0Tianhao Zhang1Jiajia Huang2Zhixin Huang3Zeyu Zhao4Shirong Cai5Jinping Ma6Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, ChinaDepartment of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, ChinaDepartment of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, ChinaDepartment of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, ChinaDepartment of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, ChinaDepartment of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, ChinaDepartment of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, ChinaBackground Currently, research on the role of hexokinase domain-containing protein-1 (HKDC1) in neoplasm metabolism remains sparse. This study seeks to conduct a thorough investigation of HKDC1’s potential functions across thirty-three different tumor types, utilizing data obtained from The Cancer Genome Atlas (TCGA). Method We conducted a thorough data extraction from the TCGA database, subsequently employing R (version 4.2.2) and its associated software packages for detailed analysis. Our investigation centered on evaluating the differential expression and prognostic significance of HKDC1, while also examining its connections to tumor heterogeneity, mutation profiles, and RNA modifications. Furthermore, we analyzed the relationship between HKDC1 expression and tumor immunity utilizing the TIMER analysis approach. Results A comprehensive analysis of various tumor types has revealed that HKDC1 is significantly upregulated in many malignant tumors. Importantly, patients with elevated HKDC1 levels in their tumor tissues often experience poorer prognoses. The association between HKDC1 expression, immune cell infiltration, and the existence of immune checkpoints suggests a possible connection between the tumor microenvironment and HKDC1, alongside tumor advancement. Gene set enrichment analysis (GSEA) further substantiates the idea that HKDC1 may play a role in several critical pathways and biological processes associated with neoplasm. Additionally, the overexpression of HKDC1 is influenced by promoter methylation and alterations in DNA copy number amplification. Furthermore, in vitro experiments demonstrated that silencing HKDC1 resulted in a marked reduction in the proliferation, migration, and invasion capabilities of neoplasm cells. Conclusion Our initial pan-cancer analysis provided a comprehensive understanding of the oncogenic roles of HKDC1 across diverse cancer types. Moreover, HKDC1 has the potential to serve as a significant prognostic biomarker.https://peerj.com/articles/19083.pdfHKDC1Pan-cancerPrognosisImmunologicalDNA methylation
spellingShingle Zhi Liang
Tianhao Zhang
Jiajia Huang
Zhixin Huang
Zeyu Zhao
Shirong Cai
Jinping Ma
A comprehensive prognostic and immunological analysis of hexokinase domain containing protein-1 (HKDC1) in pan-cancer
PeerJ
HKDC1
Pan-cancer
Prognosis
Immunological
DNA methylation
title A comprehensive prognostic and immunological analysis of hexokinase domain containing protein-1 (HKDC1) in pan-cancer
title_full A comprehensive prognostic and immunological analysis of hexokinase domain containing protein-1 (HKDC1) in pan-cancer
title_fullStr A comprehensive prognostic and immunological analysis of hexokinase domain containing protein-1 (HKDC1) in pan-cancer
title_full_unstemmed A comprehensive prognostic and immunological analysis of hexokinase domain containing protein-1 (HKDC1) in pan-cancer
title_short A comprehensive prognostic and immunological analysis of hexokinase domain containing protein-1 (HKDC1) in pan-cancer
title_sort comprehensive prognostic and immunological analysis of hexokinase domain containing protein 1 hkdc1 in pan cancer
topic HKDC1
Pan-cancer
Prognosis
Immunological
DNA methylation
url https://peerj.com/articles/19083.pdf
work_keys_str_mv AT zhiliang acomprehensiveprognosticandimmunologicalanalysisofhexokinasedomaincontainingprotein1hkdc1inpancancer
AT tianhaozhang acomprehensiveprognosticandimmunologicalanalysisofhexokinasedomaincontainingprotein1hkdc1inpancancer
AT jiajiahuang acomprehensiveprognosticandimmunologicalanalysisofhexokinasedomaincontainingprotein1hkdc1inpancancer
AT zhixinhuang acomprehensiveprognosticandimmunologicalanalysisofhexokinasedomaincontainingprotein1hkdc1inpancancer
AT zeyuzhao acomprehensiveprognosticandimmunologicalanalysisofhexokinasedomaincontainingprotein1hkdc1inpancancer
AT shirongcai acomprehensiveprognosticandimmunologicalanalysisofhexokinasedomaincontainingprotein1hkdc1inpancancer
AT jinpingma acomprehensiveprognosticandimmunologicalanalysisofhexokinasedomaincontainingprotein1hkdc1inpancancer
AT zhiliang comprehensiveprognosticandimmunologicalanalysisofhexokinasedomaincontainingprotein1hkdc1inpancancer
AT tianhaozhang comprehensiveprognosticandimmunologicalanalysisofhexokinasedomaincontainingprotein1hkdc1inpancancer
AT jiajiahuang comprehensiveprognosticandimmunologicalanalysisofhexokinasedomaincontainingprotein1hkdc1inpancancer
AT zhixinhuang comprehensiveprognosticandimmunologicalanalysisofhexokinasedomaincontainingprotein1hkdc1inpancancer
AT zeyuzhao comprehensiveprognosticandimmunologicalanalysisofhexokinasedomaincontainingprotein1hkdc1inpancancer
AT shirongcai comprehensiveprognosticandimmunologicalanalysisofhexokinasedomaincontainingprotein1hkdc1inpancancer
AT jinpingma comprehensiveprognosticandimmunologicalanalysisofhexokinasedomaincontainingprotein1hkdc1inpancancer